
# Drugs and candidates for 2019-nCoV

According to evidence-based drug R&D, we only collected the drug candidate datasets with precinical and clinical evidence. Those suggested by expert systems or predictive models were not included.

| Drug Name                | Structure                                                                              | MoA                      | Indication                                    | DrugBank URL                                     | Anti-2019nCoV Evidence         | Reference                                                                                                         |
|--------------------------|----------------------------------------------------------------------------------------|--------------------------|-----------------------------------------------|--------------------------------------------------|--------------------------------|-------------------------------------------------------------------------------------------------------------------|
| Lopinavir                | ![img1](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_lopinavir.png)   | Protease inhibitor,      | Anti-HIV approved                             | [DB01601](https://www.drugbank.ca/drugs/DB01601) | Clinical report                | [1](http://www.chinanews.com/gn/2020/01-23/9068434.shtml), [2](http://www.chictr.org.cn/showproj.aspx?proj=48782) |
| Ritonavir                | ![img2](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_ritonavir.png)   | Protease inhibitor,      | Anti-HIV approved                             | [DB00503](https://www.drugbank.ca/drugs/DB00503) | Clinical report/Cellular Assay | [1](http://www.bjnews.com.cn/news/2020/01/29/681012.html?from=timeline&isappinstalled=0)                          |
| Remdesivir, GS-5734      | ![img3](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_remdesivir.png)  | Protease inhibitor       | Anti-HIV approved; anti-Ebola passed PhaseIII | [DB14761](https://www.drugbank.ca/drugs/DB14761) | Cellular Assay                 | [1](http://www.bjnews.com.cn/news/2020/01/29/681012.html?from=timeline&isappinstalled=0)                          |
| Chloroquine, Sigma-C6628 | ![img4](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_chloroquine.png) | Inhibitor                | Antimalarial agent                            | [DB14761](https://www.drugbank.ca/drugs/DB14761) | Cellular Assay                 | [1](http://www.bjnews.com.cn/news/2020/01/29/681012.html?from=timeline&isappinstalled=0)                          |
| Arbidol (Umifenovir)     | ![img5](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_arbidol.png)     | Inhibitor                | Phase 4                                       | [DB13609](https://www.drugbank.ca/drugs/DB13609) | Clinical trial                 | [1](https://clinicaltrials.gov/ct2/show/NCT04246242)                                                              |
| Favipiravir              | ![img6](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_favipiravir.png) | RNA polymerase inhibitor | Influenza drug                                | [DB12466](https://www.drugbank.ca/drugs/DB12466) | Clinical trial                 | [1](https://xueqiu.com/8965749698/140230598)                                                                      |
| Nelfinavir               | ![img7](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_nelfinavir.png)  | Protease inhibitor       | Anti-HIV approved                             | [DB00220](https://www.drugbank.ca/drugs/DB00220) | Clinical trial                 | [1](https://xueqiu.com/8965749698/140230598)                                                                      |
| IFN alpha-1b             |                                                                                        | Interferon               | Used with Anti-HIV drugs                      |                                                  | Clinical trial                 | [1](http://www.chictr.org.cn/showproj.aspx?proj=48782)                                                            |

[Download (including SMILES structures)](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_clinicalncov.xlsx)

# Potential drug candidates by drug repuposing

High-quality drug lists were collected and curated using anti-coronavirus indications in drug development. 

 * Dataset: [Drugs in pipeline for SARS](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_druglist_)
 * Datasets: [Drugs in pipeline for MERS](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_druglist_)
 * Datasets: [Drugs in pipeline for Coronavirus, excluded SARS/MERS](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_druglist_)
 * Dataset: [FDA approved set (From Drugbank)](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_druglist_)



Quick Links:
 * Drug Information: [Drugbank](https://www.drugbank.ca/)
 * Pharmacology data: [ChEMBL](https://www.ebi.ac.uk/chembl/)
 * [PubChem](https://pubchem.ncbi.nlm.nih.gov/)
 * [BindingDB](https://www.bindingdb.org/bind/index.jsp)

 * [Epidemic updates (DXY.cn)](https://ncov.dxy.cn/ncovh5/view/pneumonia?scene=2&clicktime=1579579384&enterid=1579579384&from=timeline&isappinstalled=0)
 * [Research updates from Elsevier](https://www.elsevier.com/connect/coronavirus-information-center)

 * [Clinical Data for Coronavirus](https://clinicaltrials.gov/)
 * [新冠状病毒国家科技资源服务系统(国家微生物科学数据中心和国家病原微生物资源库)](http://nmdc.cn/#/nCoV)
 * [2019新型冠状病毒信息库(国家生物信息中心和国家基因组科学数据中心)](https://bigd.big.ac.cn/ncov)







